{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:34:03Z","timestamp":1786736043314,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jcrt.jcrt_227_19","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T05:44:58Z","timestamp":1578635098000},"page":"1496","source":"Crossref","is-referenced-by-count":3,"title":["<sup>125<\/sup>\n                    I implantation under computed tomography guidance to treat patients with recurrent pelvic tumors: Retrospective analysis of clinical results"],"prefix":"10.4103","volume":"15","author":[{"given":"Zhou","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Ruoyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Guangsheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.275548-1","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study","author":"Moore","year":"2004","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.275548-2","unstructured":"Tang Z. Modern Oncology. Shanghai: Fudan University Press; 2011. p. 1123."},{"key":"key-10.4103\/0973-1482.275548-3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0973-1482.275548-4","first-page":"242","article-title":"Diagnosis and treatment of recurrent cervical cancer","author":"Li","year":"1994","journal-title":"J Pract Gynecol Obst"},{"key":"key-10.4103\/0973-1482.275548-5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1096-9098(200001)73:1<47::AID-JSO12>3.0.CO;2-M","article-title":"Locally recurrent rectal cancer: Role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence","author":"Temple","year":"2000","journal-title":"J Surg Oncol"},{"key":"key-10.4103\/0973-1482.275548-6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejso.2006.09.021","article-title":"Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer","author":"Vermaas","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"key-10.4103\/0973-1482.275548-7","first-page":"435","article-title":"Management of recurrent cervical cancer.Review of the literature and case report","author":"Elst","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"key-10.4103\/0973-1482.275548-8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/lary.23527","article-title":"Postoperative 125 I brachytherapy delivered by digital model obturators for recurrent or locally advanced maxillary cancers","author":"Huang","year":"2012","journal-title":"Laryngoscope"},{"key":"key-10.4103\/0973-1482.275548-9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/cas.12501","article-title":"Phase II study of FOLFIRINOX for chemotherapy-na\u00efve Japanese patients with metastatic pancreatic cancer","author":"Okusaka","year":"2014","journal-title":"Cancer Sci"},{"key":"key-10.4103\/0973-1482.275548-10","first-page":"631","article-title":"125 I seeds implantation for pelvic and retroperitoneal tumors: An analysis of 23 cases","author":"Lou","year":"2016","journal-title":"Int Radiol J"},{"key":"key-10.4103\/0973-1482.275548-11","first-page":"666","article-title":"Environmental radiation dose monitor after 125 I radioactive seed implantation","author":"Zhuo","year":"2007","journal-title":"Ai Zheng"},{"key":"key-10.4103\/0973-1482.275548-12","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1038\/s41598-017-03831-5","article-title":"Iodine-125 brachytherapy prophylaxis after radiofrequency ablation cannot benefit patients in high risk of locoregional hepatocellular carcinoma recurrence","author":"Tu","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/0973-1482.275548-13","first-page":"1457","article-title":"Evaluation of CT-guided iodine-125 seeds brachytherapy for intracranial malignant tumors under control of target and dose","author":"Hu","year":"2017","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key-10.4103\/0973-1482.275548-14","first-page":"1492","article-title":"Quality of life after I-125 seed implantation using computed tomography and three-dimensional-printed template guidance in patients with advanced malignant tumor","author":"Wang","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"key-10.4103\/0973-1482.275548-15","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/1097-0142(19910515)67:10<2467::AID-CNCR2820671013>3.0.CO;2-K","article-title":"Iodine-125 interstitial implants as salvage therapy for recurrent gynecologic malignancies","author":"Sharma","year":"1991","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.275548-16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1748-717X-6-138","article-title":"Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma","author":"Wang","year":"2011","journal-title":"Radiat Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:36:34Z","timestamp":1786732594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_227_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"alternative-id":["275548"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_227_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}